rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2003-7-25
|
pubmed:abstractText |
Analysis of the issue of screening for Factor V Leiden mutation (FVL) in users of combined oral contraceptives (COC) or hormone replacement therapy (HRT).
|
pubmed:language |
cze
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1210-7832
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
167-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12879655-Contraceptives, Oral, Combined,
pubmed-meshheading:12879655-Contraceptives, Oral, Hormonal,
pubmed-meshheading:12879655-Estrogen Replacement Therapy,
pubmed-meshheading:12879655-Factor V,
pubmed-meshheading:12879655-Female,
pubmed-meshheading:12879655-Genetic Markers,
pubmed-meshheading:12879655-Genetic Predisposition to Disease,
pubmed-meshheading:12879655-Humans,
pubmed-meshheading:12879655-Point Mutation,
pubmed-meshheading:12879655-Risk Factors,
pubmed-meshheading:12879655-Thrombophilia
|
pubmed:year |
2003
|
pubmed:articleTitle |
[Screening for factor V Leiden mutation in women using combined hormonal contraceptives or hormone replacement therapy].
|
pubmed:affiliation |
Gynekologicko-porodnická klinika 1. LF UK a VFN v Praze. david.cibula@oil.cz
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|